Siemens: Ask the Ultimate Power ... ( Siemens' portfolio of innovations and...)

Siemens: Ask the Ultimate Power in Imaging

Date:11/30/2008

Siemens' portfolio of innovations and workflow solutions take center stage at RSNA 2008

CHICAGO, Nov. 30 /PRNewswire-FirstCall/ -- At the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, November 30 to December 5, Siemens Healthcare (www.siemens.com/healthcare)will demonstrate its latest diagnostic imaging innovations in computed tomography, mammography, magnetic resonance, molecular imaging, ultrasound, and much more at the Siemens booth (Booth #922, East Building/Lakeside Center, Hall D).

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

"There is huge potential to increase the quality and efficiency of healthcare through technological innovation and workflow improvements," said Hermann Requardt, CEO, Siemens Healthcare Sector. "Since 1847 Siemens is renowned for its unrivaled strength in research and development, resulting in the leadership position we hold today. As the world's leading integrated technology company, Siemens brings unparalleled innovations to the medical industry."

Taking center stage at the booth, Siemens' Innovations@RSNA launch area will feature a theater where attendees, through interviews with Siemens' experts, can learn more about the latest technologies and how they are shaping the industry. Interviews are scheduled to take place every half hour while the exhibit hall is opened.

"Siemens' technology is designed to help our customers become successful and achieve their goals," said Dr. Bernd Montag, CEO, Imaging & IT Division, Siemens Healthcare Sector. "By dovetailing our technological expertise and engineering excellence with our deep clinical insights and a fundamental understanding of
'/>"/>

SOURCE Siemens Healthcare
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:7/3/2009)...if. The newest revolution in microbiology testing ...ir sheep, a less-hirsute version of the familiar w...ford University School of Medicine, which is to be...ly are these ruminants low-maintenance and parasit... the microbiology tests necessary to diagnose infe...

(Date:7/3/2009)...may thwart treatment-resistant strain, study finds... -- Extreme drug-resistant tuberculosis might some...Parkinson,s disease, suggests a new study. , ...California, San Diego, report in the July 3 issue ...available entacapone and tolcapone have the potent...

(Date:7/3/2009)...uly 3 Republicans on th...e in health care reform legislation that would eli...pens, many women could lose coverage for abortion ...cludes. Plus, millions of uninsured women will sti... been promised a better quality of life. , , If...

(Date:7/3/2009)... Two companies and three individuals have ...n annual international competition designed to rew...,000-member SafetyXChange.org community released i...009 at http://www.safetyxchange.org/saxcies-video...tions who dedicate their lives to keeping others s...

Breaking Medicine News(10 mins):Health News:Rare sheep could be key to better diagnostic tests in developing world, says Stanford study 2 Health News:Rare sheep could be key to better diagnostic tests in developing world, says Stanford study 3 Health News:New Weapons in Fight Against TB? 2 Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 2 Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 3 Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 4

[0] Rare sheep could be key to better diagnostic tests in developing world, says Stanford study [0] New Weapons in Fight Against TB?[0] Republicans on Senate Committee Push to Exclude Abortion Services from Health Care Reform [0] Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named

... detectable level of prostate-specific antigen (PS...ncer after radical// prostatectomy. In a new May...DT) is found to be a reliable tool to distinguish ...s PSA levels after therapy from those who are at g...

...rug abuse is increasing at an alarming rate in Aus...young as 14 are turning to drugs and at least one ...cording to Statistics on Drug Use in Australia 200...nstitute of Health and Welfare. According to the...

...ertility declining among men of north India. And t... the All India Institute of Medical Sciences// (AI...medical institution actually reveals a dramatic fa...y. The sperm count of a normal adult male in Indi...

...MA President, Dr Mukesh Haikerwal, said today that...n population must be the priority of any health re...tralian Governments (COAG) meeting. Dr Haikerwal ...s if the State and Territory Governments do the ri...

Other Medicine News:Health News:Alarming Rise of Methamphetamine Use Among Australian Youth 2 Health News:Denim Lovers Beware, Fertility Could Be in Danger, Says a New Study 2

PSA Doubling Predicts Prostate Cancer Recurrence Alarming Rise of Methamphetamine Use Among Australian Youth Denim Lovers Beware, Fertility Could Be in Danger, Says a New Study AMA Urges COAG To Put Patients First

(Date:6/28/2009)...ICHMOND, Calif., June 29 ... announced that a key research milestone has been ...h Genentech, Inc., a wholly-owned member of the Ro...ovel characteristics for pharmaceutical protein pr... finger DNA-binding protein nuclease (ZFN) technol...

(Date:6/26/2009)...RIDGEWATER, N.J., June 26 /PRNewswire-FirstCall/ -...) has just been made aware of data associated with...ies. The results of these data clearly show that n...possible causal relationship between Lantus(R) (in...rence of malignancies, as the authors of the study...

(Date:6/25/2009)... Thirteen Renowned Medical Experts Slated to Atten..., June 25 The first national sympo...rgy drinks will be held next week in New York City...rch and analysis from their respective fields. Th...ion and research on the health impacts that the $5...

(Date:6/25/2009)...CUROX(R) and EMBEDA (TM) Data Highlighted at the C...ng , , RENO, Nev., June 25 Ki...nced that the Company is presenting safety and eff..., two novel opioid analgesic formulations that are... College on Problems of Drug Dependence. King is ...

[0] Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech [0] Sanofi-aventis Stands Behind the Safety of Lantus(R)[0] SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts [0] King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use

...ALT LAKE CITY, UT, June 11, 2007 (MARKET WIRE via ...DAQ: MYGN) (<a target=,"_blank" href="http://www.m...it presented a mathematical comparison of a,"Stagg... trial,design with a "Natural History Staggered St...ciation Prevention Conference held,June 9 - 12, 20...

...LTHAM, Mass.--(BUSINESS WIRE)--Jun 12, 2007 - Resu...Pharmaceuticals, (Nasdaq:,OSCI) FACTIVE(R) (gemifl...t of community-acquired pneumonia of mild to moder... issue of the,peer-reviewed Journal of Antimicrobi...-line. The data from the Phase III clinical,trial ...

Other Medicine Technology:Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 2 Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 3 Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 4 Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 5 July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 2 July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 3 July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 4 July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 5

Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia

Inquire

The Cypress quick test is a rapid immunochromatographic screening test for the detection of antibodies to Trypanosoma cruzi. It can be used with whole blood, serum or plasma. The method employs a un

Sprint Quattro Secure™ is a Steroid-Eluting, True Bipolar, Active Fixation ICD Lead.

The Medtronic Subcutaneous Lead System Model 6996 SQ is implanted subcutaneously with the use of the Medtronic Tunneling Tool Model 6996T. Improved SQ design and implant technique offer low DFTs, a f

Medicine Products:

Chagas Microplate ELISA Chagas Quick Step Sprint Quattro Secure™ 6947 Subcutaneous Lead System Model 6996SQ

Siemens: Ask the Ultimate Power ...( Siemens' portfolio of innovations and...),Health